Related Experiment Video
Updated: Jul 12, 2026
05:06
Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
Published on: July 14, 2023
Diabetic peripheral neuropathic pain: recognition and management
1American Society of Pain Educators, Montclair, New Jersey 07042, USA. bc@mededucators.com
Pain Medicine (Malden, Mass.)
|October 17, 2007
Summary
Diabetic peripheral neuropathic pain (DPNP) is a disabling condition linked to diabetes. Duloxetine is a new FDA-approved medication shown to effectively manage DPNP and associated depression.
Area of Science:
- Neurology
- Endocrinology
- Pharmacology
Background:
- Diabetic peripheral neuropathy (DPN) is a common complication of diabetes, often linked to poor glycemic control.
- A subset of individuals with DPN develop diabetic peripheral neuropathic pain (DPNP), a debilitating condition.
- Historically, limited FDA-approved pharmacologic options existed for DPNP management.
Purpose of the Study:
- To examine the epidemiology, pathogenesis, evaluation, and treatment of DPNP.
- To highlight the role of duloxetine as an effective treatment option for DPNP.
Main Methods:
- Review of existing literature on DPNP epidemiology and pathogenesis.
- Analysis of clinical trial data for duloxetine in DPNP treatment.
- Discussion of diagnostic and management strategies for DPNP.
Main Results:
- DPNP affects a significant number of individuals with DPN, causing disability.
- Duloxetine, a serotonin-norepinephrine reuptake inhibitor, has demonstrated efficacy in improving DPNP and comorbid depression.
- Two FDA-approved medications are now available for DPNP treatment.
Conclusions:
- DPNP is a significant clinical challenge requiring effective management strategies.
- Duloxetine represents a key therapeutic advancement for patients suffering from DPNP and depression.
- Continued research and clinical attention are necessary for optimal DPNP care.
Related Concept Videos
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...